Neuroblastoma trials in Italy

In Italy 8 Also abroad 128

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Milan, Rome, Turin
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
No phaseTaking people
Prospective Multicenter Study of the Genomic, Transcriptomic, and Biological Profile of Patients With Neuroblastoma
Where
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro, Cosenza, Ferrara, Florence, Genova, Milan, Modena, Naples, Padova, Palermo, Parma, Pavia, Perugia, Pescara, Pisa, Reggio Calabria, Rimini, Roma, San Giovanni Rotondo, Sassari, Siena, Torino, Trieste, Verona
Age
0 days to 31 years
People
200
Run by
Istituto Giannina Gaslini
See details and how to joinNCT07881172
Phase 1/2Taking people
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Where
Milan, Rome, Turin
Age
Up to 64 years
People
72 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 · EU 2023-504880-18-00
Phase 1/2Taking people
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Where
Florence, Genoa, Milan, Padova, Rome, Turin
Age
1 year to 64 years
People
160 worldwide
Run by
University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00
Phase 1Taking people
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Where
Genoa, Rome
Age
18 months to 18 years
People
38 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00
Phase 3Taking people
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Where
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro, Firenze, Genoa, Milan, Modena, Naples, Padova, Palermo, Parma, Pavia, Perugia, Pescara, Pisa, Rimini, Rome, San Giovanni Rotondo, Torino, Trieste, Verona
Age
Up to 21 years
People
800 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00
Phase 1/2Taking people
Phase I/II study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by High Risk and/or relapsed/refractory Neuroblastoma and other relapsed/refractory GD2+ tumors
Where
Rome
Age
Up to 64 years
People
54
Run by
Ospedale Pediatrico Bambino Gesu
See details and how to join2024-520436-15-00 · EU 2024-520436-15-00
Phase 2Taking people
TCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neuroblastoma
Where
Genoa
Age
Up to 64 years
People
19
Run by
IRCCS Istituto Giannina Gaslini
See details and how to join2024-519089-32-02 · EU 2024-519089-32-02